Onmark Signs Exclusive Contracts with Pfizer Inc. (PFE) and Berlex for Oncology and Supportive Care Products
4/3/2007 10:53:23 AM
More...
|
Berlex Inc. Large Study Shows that Presence of Neutralizing Antibodies Did Not Predict Clinical Response to Betaseron Treatment
4/2/2007 11:23:54 AM
More...
|
Biotech Industry is Down, for Now -- Berlex Inc. (Jobs) Plans to Eliminate 210 East Bay Jobs
3/20/2007 2:27:30 AM
More...
|
Favrille, Inc. (FVRL) Announces Agreement With Berlex Inc. Regarding Use Of FavId(R) In Combination With Leukine(R) (sargramostim) In B-Cell Non-Hodgkin's Lymphoma
2/14/2007 12:54:38 PM
More...
|
Berlex Inc. And Premier, Inc. Sign New Agreement For Magnetic Resonance Contrast Media
1/4/2007 12:06:16 PM
More...
|
FDA Approves Berlex Inc.'s Betaseron(R) For Use After The First Event Suggestive Of Multiple Sclerosis
10/23/2006 11:27:50 AM
More...
|
FDA Approves New Indication For Berlex Inc.'s YAZ(R) To Treat Emotional And Physical Symptoms Of Premenstrual Dysphoric Disorder (PMDD)
10/5/2006 9:25:05 AM
More...
|
Berlex Inc. Issues Nationwide Recall Of A Single Lot Of Ultravist(R) Injection 370 mgI/mL, 125 mL In The U.S.
7/20/2006 6:37:20 PM
More...
|
Berlex Inc. Release: New Autoinjection Device Designed To Work With Betaseron(R) Now Available For Patients With Multiple Sclerosis
7/11/2006 11:06:38 AM
More...
|
Confirma, Inc. Products Now Available Through Berlex Inc.'s Accrual Program
5/22/2006 2:13:55 PM
More...
|
|